Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year
暂无分享,去创建一个
R. Viner | E. Draper | L. Fraser | D. Hargreaves | S. Ladhani | J. Ward | S. Turner | M. Clark | K. Luyt | E. Whittaker | R. Harwood | S. Kenny | P. Davis | M. Linney | Clare Smith
[1] E. Draper,et al. In the eye of the storm: impact of COVID-19 pandemic on admission patterns to paediatric intensive care units in the UK and Eire , 2021, Critical Care.
[2] R. Viner,et al. Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year , 2021, Nature Medicine.
[3] M. Tobin-D'Angelo,et al. Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States , 2021, Pediatrics.
[4] R. Viner,et al. Deaths in Children and Young People in England following SARS-CoV-2 infection during the first pandemic year: a national study using linked mandatory child death reporting data , 2021, medRxiv.
[5] R. Viner,et al. Which children and young people are at higher risk of severe disease and death after SARS-CoV-2 infection: a systematic review and individual patient meta-analysis , 2021, medRxiv.
[6] Karen K. Wong,et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children , 2021, JAMA network open.
[7] K. Bhaskaran,et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform , 2021, The Lancet.
[8] M. Tobin-D'Angelo,et al. Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic. , 2021, JAMA pediatrics.
[9] K. Khunti,et al. Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID‐19: Analysis of the ISARIC CCP‐UK Cohort , 2021, Obesity.
[10] S. Ladhani,et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020 , 2021, The Lancet Regional Health - Europe.
[11] R. Bhopal,et al. Children and young people remain at low risk of COVID-19 mortality , 2021, The Lancet Child & Adolescent Health.
[12] L. Smeeth,et al. Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform , 2021, The Lancet Regional Health - Europe.
[13] K. Bhaskaran,et al. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform , 2020, The Lancet HIV.
[14] Ricardo Queiroz Gurgel,et al. Coronavirus disease‐19 deaths among children and adolescents in an area of Northeast, Brazil: why so many? , 2020, Tropical medicine & international health : TM & IH.
[15] Joseph M. Campos,et al. Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children , 2020, JAMA network open.
[16] Álvaro Freitas Moreira,et al. Multisystem inflammatory syndrome in children: A systematic review , 2020, EClinicalMedicine.
[17] Sohan Seth,et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study , 2020, BMJ.
[18] P. Davies,et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study , 2020, The Lancet Child & Adolescent Health.
[19] K. Bhaskaran,et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.
[20] C. Murray,et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.
[21] P. Horby,et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol , 2020, medRxiv.
[22] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[23] N. G. Davies,et al. Age-dependent effects in the transmission and control of COVID-19 epidemics , 2020, Nature Medicine.
[24] R. Gilbert,et al. Estimating the prevalence of chronic conditions in children who die in England, Scotland and Wales: a data linkage cohort study , 2014, BMJ Open.
[25] Jérôme Hugues,et al. Model‐Based Analysis , 2013 .
[26] L. Fraser,et al. Rising National Prevalence of Life-Limiting Conditions in Children in England , 2012, Pediatrics.
[27] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[28] A. Garg,et al. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.